Skip to content

Study of the effect of the food containing plant-derived ingredient X on sleep

Study of the effect of the food containing plant-derived ingredient X on sleep - The effect of the plant-derived ingredient X on sleep

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000041585
Enrollment
72
Registered
2020-08-28
Start date
2019-10-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Sponsors

Kao Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Adults aged from 30 to 49, or 60 to 69 2) Healthy subjects with no serious disorders 3) Subjects who have dissatisfaction with sleep

Exclusion criteria

Exclusion criteria: 1) Having history or presence of serious disorders 2) Presence of disorders about sleep 3) Taking hypnotics or psychotropic drug 4) Planned to who take a health food about sleep or stress 5) Pregnancies and lactations 6) Heavy alcohol drinker (over 60g per day) 7) Habitually taking much coffee (over five cups per day) 8) Food allergy, drug allergy, metal allergy, or any allergy 9) Feeling discomfort while sleeping with wearing activity monitor attached 10) Subjects who herself and/or her family members are working for an advertising agency, investigation and consultant business, and a mass media-related company, the food company, the cosmetics company, the toiletry company, and company in manufacturing and distribution 11) Planned to participate in other clinical study during current study 12) Determined to be unqualified by the physician in charge or the responsible person of the study

Design outcomes

Primary

MeasureTime frame
Evaluation of the OSA questionnaire before and after the 1-week treatment period

Secondary

MeasureTime frame
Evaluation of 1) the symptoms questionnaires about sleep, fatigue, stress 2) the nocturnal awakening time and sleep efficiency assessed by actigraph before and after the 1-week treatment period

Countries

Japan

Contacts

Public ContactChika Suzukamo

Kao Corporation Biological Science Research

suzukamo.chika@kao.com+81-3-5630-7266

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026